• No results found

University of Groningen Optimizing levofloxacin dose in the treatment of multidrug-resistant tuberculosis Ghimire, Samiksha

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Optimizing levofloxacin dose in the treatment of multidrug-resistant tuberculosis Ghimire, Samiksha"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Optimizing levofloxacin dose in the treatment of multidrug-resistant tuberculosis

Ghimire, Samiksha

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Ghimire, S. (2019). Optimizing levofloxacin dose in the treatment of multidrug-resistant tuberculosis: An integrated PK/PD approach. University of Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

178

Ab out Th e A ut hor

about the author

Samiksha Ghimire was born November 7th, 1988 in Saptari, Nepal. In 2010, she completed her bachelor’s degree in Human Biology with Cum Laude from Kathmandu University, Nepal. From 2010-2012, she worked as a graduate teaching assistant at the Department of Pharma-cology at Kathmandu University. 2015, she graduated as a master’s in Medical Pharmaceutical Sciences from University of Groningen, the Netherlands. During three months of summer in 2014, she worked as an intern at Nordic Bioscience, a drug and biomarker development company in Copenhagen, Denmark. Samiksha Ghimire was in 2015 selected for Eric Bleumink Talent Grant to pursue a PhD degree at the department of Clinical Pharmacy and Pharmacology at University Medical Center Groningen. The PhD project focused on finding ways to optimize doses of currently used anti-TB drugs in the treatment of multi-drug resistant tuberculosis.

Samiksha loves nature and derives great pleasure from hiking in the mountains. Also, she likes travelling, leisure reading and cooking, and above all, she treasures deep connection with beloved humans.

Referenties

GERELATEERDE DOCUMENTEN

Treatment success rate is a potentially biased outcome parameter; our primary efficacy end point to estimate the usefulness of LFX was time to sputum culture conversion within

The last study [33] developed and validated a liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) method for the analysis of

Therefore, membrane filtration was found to be suitable for sterilization of saliva samples, before analyzing for therapeutic drug monitoring purposes (7). However, it is likely that

In this prospective pharmacokinetic study (May 2016 to October 2017; ERB approval no. 115/2016), we aimed to evaluate the factors associated with time to sputum culture conversion

Saliva may be a useful alternative matrix for monitoring levofloxacin concentrations in multi-drug resistant TB patients. The objectives of this study were: a) to evaluate

Achieving optimal target exposure was positively associated with treatment success in MDR-TB patients based on observational studies.. In a hollow fiber model of TB,

Through our findings, we have shown that currently used levofloxacin dose in MDR-TB patients is inadequate and how sub-optimal drug concentrations in combination with higher MICs

De resultaten van de gevonden studies lieten zien dat 80% van de volwassen MDR-TB patiënten met een hoge minimaal remmende concentratie (MIC, maat voor de gevoeligheid van